CCCC
CCCC clinical trials: C4 Therapeutics, Inc.
Every trial on ClinicalTrials.gov where C4 Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CCCC on the catalyst calendar · CCCC registry changes
- Primary completion Mar 2030Sponsor estimatePhase 2NCT07284758A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaC4 Therapeutics, Inc. · Multiple MyelomaRecruitingCCCCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2028Sponsor estimatePhase 1NCT07280013A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsC4 Therapeutics, Inc. · Multiple Myeloma (MM)RecruitingCCCCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2026Sponsor estimatePhase 1NCT04756726Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaC4 Therapeutics, Inc. · Multiple MyelomaActive, not recruitingCCCCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 5, 2025ActualPhase 1NCT05668585A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects...C4 Therapeutics, Inc. · Solid TumorsCompletedCCCCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2023ActualPhase 1NCT05355753A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial...C4 Therapeutics, Inc. · Synovial SarcomaTerminatedCCCCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner